# Astaxanthin Formulation Bioavailability

> **NCT02397811** · NA · COMPLETED · sponsor: **Cyanotech Corporation** · enrollment: 12 (actual)

## Conditions studied

- Bioavailability of Astaxanthin Formulations

## Interventions

- **DIETARY_SUPPLEMENT:** Enteric Coated Softgels
- **DIETARY_SUPPLEMENT:** Liposomal astaxanthin
- **DIETARY_SUPPLEMENT:** Standard Softgel
- **DIETARY_SUPPLEMENT:** Astaxanthin Water Soluble Emulsion
- **DIETARY_SUPPLEMENT:** Astaxanthin Water Dispersible Powder
- **DIETARY_SUPPLEMENT:** Standard Softgel with Astaxanthin Gel

## Key facts

- **NCT ID:** NCT02397811
- **Lead sponsor:** Cyanotech Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02397811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02397811, "Astaxanthin Formulation Bioavailability". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02397811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*